[ascct] Fwd: CAATwalk: News and Updates
- From: Kristie Sullivan <KSullivan@xxxxxxxx>
- To: "ascct@xxxxxxxxxxxxx" <ascct@xxxxxxxxxxxxx>
- Date: Wed, 6 Feb 2013 16:33:31 -0500
Dear Colleagues,
Please see below for the latest upcoming events from CAAT. You can see a web
version of the newsletter here:
http://us4.campaign-archive2.com/?u=066d5d7abe2de2d5e04d214bf&id=71fccd3c68&e=4c7d58c42f
Kristie Sullivan
Secretary, ASCCT
www.ascctox.org<http://www.ascctox.org>
Begin forwarded message:
From: Center for Alternatives to Animal Testing (CAAT)
<caat@xxxxxxxxx<mailto:caat@xxxxxxxxx>>
Subject: CAATwalk: News and Updates
Date: February 6, 2013 12:56:20 PM PST
To:
Reply-To: Center for Alternatives to Animal Testing (CAAT)
<caat@xxxxxxxxx<mailto:caat@xxxxxxxxx>>
Updates from the Center for Alternatives to Animal Testing (CAAT)
Email not displaying correctly?
View it in your
browser<http://us4.campaign-archive2.com/?u=066d5d7abe2de2d5e04d214bf&id=71fccd3c68&e=4c7d58c42f>.
[http://gallery.mailchimp.com/066d5d7abe2de2d5e04d214bf/images/caatlogo.2.jpg]<http://jhsph.us4.list-manage1.com/track/click?u=066d5d7abe2de2d5e04d214bf&id=53e5e82ff9&e=4c7d58c42f>
[http://gallery.mailchimp.com/27aac8a65e64c994c4416d6b8/images/twitter_24x24_p50.png]
<http://jhsph.us4.list-manage1.com/track/click?u=066d5d7abe2de2d5e04d214bf&id=39d6bcb80c&e=4c7d58c42f>
[http://gallery.mailchimp.com/27aac8a65e64c994c4416d6b8/images/facebook_24x24_p50.png]
<http://jhsph.us4.list-manage.com/track/click?u=066d5d7abe2de2d5e04d214bf&id=d485ed0dc2&e=4c7d58c42f>
CAATwalk February 6, 2013
February brings with it this year's call for proposals for CAAT's 2014-2015
grants, along with announcements of several important meetings. If you plan to
attend, please be sure to add them to your calendar and make travel
arrangements soon. And as always, feel free to forward this newsletter to your
colleagues.
Satellite Meeting at Society of Toxicology (SOT): Updates on 21st Century
Toxicology Activities and Related Efforts
Thursday, March 14, 2013 (Immediately after SOT ends)
12:30pm - 4pm
San Antonio, Texas
Grand Hyatt Presidio Room
Presented by CAAT
This meeting will provide a forum for interested stakeholders to update each
other on efforts to advance pathway-based approaches to toxicology, as
exemplified by the 2007 National Research Council report on “Toxicity Testing
in the 21st Century” (“TT21C”). The meeting also will address efforts to
promote the use of systematic reviews and related evidence-based approaches in
toxicology, with an emphasis on their relevance to TT21C.
Full SOT 2013
Calendar<http://jhsph.us4.list-manage1.com/track/click?u=066d5d7abe2de2d5e04d214bf&id=92bd3b8ea9&e=4c7d58c42f>
(PDF)
Program
12:30 Box lunch and Welcome, Thomas Hartung (Johns Hopkins University)
13:00 Invited Presentations (10 minutes each plus 5 minutes for discussion)
* David Dix (US Environmental Protection Agency) – ToxCast Update
* Raymond Tice (US National Institute of Environmental Health Science) –
Tox21 Update
* Russell Thomas (Hamner Institutes for Biomedical Sciences) – Hamner
TT21C-related Activity Update
* Thomas Hartung (Johns Hopkins) – The Center for Alternatives to Animal
Testing’s TT21C-related Activity Update
* Richard Judson (US EPA) – Validation of High-throughput Assays
* Martin Stephens (Johns Hopkins) – Evidence-based Toxicology Update
14:30 Open microphone for additional presentations and discussion
16:00 Adjourn
Questions? Please contact Marilyn
Principe<http://jhsph.us4.list-manage.com/track/click?u=066d5d7abe2de2d5e04d214bf&id=46782b7e8f&e=4c7d58c42f>.
________________________________
EU Science: Global Challenges and Global Cooperation
March 4-8, 2013
European Parliament, Brussels
Details and
Registration:http://www.globalsciencecollaboration.org<http://jhsph.us4.list-manage.com/track/click?u=066d5d7abe2de2d5e04d214bf&id=a83cf041fe&e=4c7d58c42f>
Downloadable
Flyer<http://jhsph.us4.list-manage.com/track/click?u=066d5d7abe2de2d5e04d214bf&id=ba615723a5&e=4c7d58c42f>
(PDF)
March 7th: New Regulatory Science in Systems Toxicology
UPDATE ON THE KNOWLEDGE or PARADIGM SHIFT? Panel Discussion and Audience
Questions
* Thomas Hartung- Director, Center for Alternatives to Animal Testing (CAAT)
* Emily McIvor– HSI
* Donald Prater– FDA
* Adrianno Henney– VIRTUAL LIVER
* Rex Fitzgerald– SCAHT
* Robert Barouki – INSERM
* Francois Busquet– CAAT EUROPE– as MODERATOR
Worldwide Implementation of the 3Rs in Regulatory Toxicology: What are the
Leadership Challenges and Opportunities?
Panel Discussion and Presentations
* 3Rs Implementation in North America
Paul Locke- Policy Program Director, Center for Alternatives to Animal Testing
(CAAT)
* 3Rs Implementation in Latin America
Octavio Presgrave- BraCVAM
* 3Rs Implementation in the EU
Björn Hansen- EC
* 3Rs Implementation in Japan, India, China, and Korea (Pacific Basin)
Richard Fosse- GSK
* 3Rs Implementation in Australia
Brett Lidbury- Australian National University
* Final Presentation: 3Rs Wrap-up and Summary What We Have Learned Today on
the State of the Implementation of the 3Rs
Joyce Tischler– Animal Legal Defense Fund
________________________________
Workshop: Lessons Learned, Challenges, and Opportunities: The US Endocrine
Disruptor Screening Program
April 23-24, 2013, Research Triangle Park, NC
This workshop brings together multiple stakeholders including CAAT as
co-organizer in an open forum to review and discuss the challenges and lessons
learned from the initial experiences with Tier 1 screening assays. This open
meeting, with all stakeholders—including Federal Regulatory Agencies, NGOs,
industry, contract laboratory scientists, and academic researchers—is critical,
and timely, to utilize the collective experience for potential improvements in
Tier 1 assays and to further advance endocrine disruption assessment. All
stakeholders and interested parties are invited to participate.
Information and Registration:
http://www.tera.org/peer/edsp<http://jhsph.us4.list-manage.com/track/click?u=066d5d7abe2de2d5e04d214bf&id=91021e817a&e=4c7d58c42f>
________________________________
Clinical Trial and Error: Beauty and the Beast
February 15, 2013, Boston, MA
3-4:30pm
Hynes Convention Center, Room 309
At the AAAS 2013 Annual Meeting
Independent clinical trials are fundamental to improving the results, safety,
and cost-effectiveness of health care. Because of costs, the scope of these
trials is often limited to new products. Important clinical interventions,
surgery, physiotherapy, and rehabilitation are of less interest to commercial
sponsors seeking primarily drug and device authorization. Whereas
investigator-driven studies now find support in the United States and European
Union, they cannot match the resources available for commercial clinical
trials. Public and charitable funding typically backs health care–orientated
trials independently of manufacturers, but is often much smaller in size.
Results matter. When we do get such new evidence, it allows us to look back:
how good was the preclinical research to start with? While evidence-based
medicine is the health care imperative of the 21st century, it remains
difficult to generate the evidence base for pressing public health challenges.
This session unites key stages and world authorities in the clinical trials
process to explain why and what must change. With expertise on leading animal
and human studies to end products, speakers will provide new insights into how
clinical trials are conducted. Their common cause will be to argue that greater
international cooperation and standards are required. That said, effective
communication of clinical and societal benefits must be better coordinated to
citizens, patients, health-care professionals, researchers, policy-makers, and
society as a whole.
Organizer: Aidan Gilligan (Irish), Founder, CEO of SciCom - Making Sense of
Science; Contact: ag@xxxxxxxxxx<mailto:ag@xxxxxxxxxx>
Moderator: Dr Klaus Bock (Danish), Champion Euroscience Open Forum 2014
Copenhagen, Member of the European Research Council’s Scientific Council
Discussants:
* Professor Anne Glover, (British), Chief Scientific Adviser to European
Commission President, José Manuel Barroso
* Wilson M. Compton, (USA), M.D., M.P.E., Director, Division of
Epidemiology, Services and Prevention Research, National Institute on Drug
Abuse, National Institutes of Health, U.S. Department of Health and Human
Services
Speakers:
* Dr. Thomas Hartung (German), Professor and Chair for Evidence-based
Toxicology, Director, Center for Alternatives to Animal Testing, Johns Hopkins
University, Bloomberg School of Public Health, Dept. of Environmental Health
Science
Look back in anger? What clinical trials tell us about pre-clinical
research<http://jhsph.us4.list-manage1.com/track/click?u=066d5d7abe2de2d5e04d214bf&id=c8cce2270f&e=4c7d58c42f>
(PDF)
* Jay Siegel (American), Chief Biotechnology Officer for Johnson & Johnson &
Head of Pharmaceutical Global Regulatory Affairs for Janssen, Janssen Research
& Development
Product-orientated versus healthcare-orientated clinical trials
* Dr. Paul J. Kenny (Irish), Associate Professor, Laboratory of Behavioral
and Molecular Neuroscience, Department of Molecular Therapeutics, The Scripps
Research Institute - Florida
The latest clinical trial research on brain reward systems
Registration and
Details:http://www.aaas.org/meetings/2013/registration/<http://jhsph.us4.list-manage.com/track/click?u=066d5d7abe2de2d5e04d214bf&id=792df2402d&e=4c7d58c42f>
________________________________
Best wishes from all of us,
The CAAT Team
[http://gallery.mailchimp.com/066d5d7abe2de2d5e04d214bf/images/jhsph2c.jpg]<http://jhsph.us4.list-manage.com/track/click?u=066d5d7abe2de2d5e04d214bf&id=5657cd6830&e=4c7d58c42f>
[http://gallery.mailchimp.com/066d5d7abe2de2d5e04d214bf/images/konstanzlogo.jpg]
<http://jhsph.us4.list-manage.com/track/click?u=066d5d7abe2de2d5e04d214bf&id=df67940435&e=4c7d58c42f>
[http://gallery.mailchimp.com/066d5d7abe2de2d5e04d214bf/images/tubes.jpg]
CAAT Grants Program: Call for Preproposals
Deadline: March 22, 2013
The Johns Hopkins Center for Alternatives to Animal Testing (CAAT) is
soliciting projects that focus on the implementation of the NAS Report:
Toxicity Testing in the 21st Century: A Vision and a Strategy in the following
area:
Proposals Relating to Toxicology: Maximum grant amount is $25,000 per year.
Projects should be developed to provide understanding of mechanism/mode of
action and to consider how one would be able to translate the mechanism to a
method that can be used to evaluate/predict health consequences.
To apply for a CAAT grant, complete the preproposal form
here<http://jhsph.us4.list-manage.com/track/click?u=066d5d7abe2de2d5e04d214bf&id=ff8f47fdc3&e=4c7d58c42f>
and return so that the submission reaches us no later than March 22, 2013.
Full details on CAAT's grant program may be found
here<http://jhsph.us4.list-manage.com/track/click?u=066d5d7abe2de2d5e04d214bf&id=2f1a54a613&e=4c7d58c42f>.
follow on
Twitter<http://jhsph.us4.list-manage.com/track/click?u=066d5d7abe2de2d5e04d214bf&id=735d957284&e=4c7d58c42f>
| friend on
Facebook<http://jhsph.us4.list-manage.com/track/click?u=066d5d7abe2de2d5e04d214bf&id=de80ce0362&e=4c7d58c42f>
| forward to a
friend<http://us4.forward-to-friend.com/forward?u=066d5d7abe2de2d5e04d214bf&id=71fccd3c68&e=4c7d58c42f>
Copyright © 2013 Johns Hopkins Center for Alternatives to Animal Testing, All
rights reserved.
You are receiving this email as a friend or colleague of CAAT.
US Office: 615 N. Wolfe St. W7032 • Baltimore, MD 21205
Phone: 410-614-4990 • Fax: 410-614-2871
European Office: University of Konstanz
POB 600 78457 Konstanz, Germany
Phone: +49-531-882233 • Fax: +49-7531-884156
unsubscribe from this
list<http://jhsph.us4.list-manage.com/unsubscribe?u=066d5d7abe2de2d5e04d214bf&id=611b893885&e=4c7d58c42f&c=71fccd3c68>
| update subscription
preferences<http://jhsph.us4.list-manage2.com/profile?u=066d5d7abe2de2d5e04d214bf&id=611b893885&e=4c7d58c42f>
Other related posts:
